Test Discontinuation Memorandum

Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following test:

  • Test code 6084 – DMD Sequence Analysis

For alternative testing, we offer DMD Comprehensive Analysis by Next Generation Sequencing (test code 20145) that includes sequencing and copy number analysis, including female carrier analysis, and a Muscular Dystrophy Panel by Next Generation Sequencing (test code 24400) that contains the following genes:

ANO5, CAPN3, CAV3, DAG1, DES, DMD, DNAJB6, DPM3, DYSF, EMD, FHL1, FKRP, FKTN, GMPPB, ISPD, LMNA, MYH7, MYOT, PLEC, POMGNT1, POMT1, POMT2, PTRF, SGCA, SGCB, SGCD, SGCG, SMCHD1, SYNE1, SYNE2, TCAP, TMEM43, TNPO3, TRAPPC11, TRIM32, TTN

Previous Post
Test Discontinuation Memorandum
Next Post
Test Updates Memorandum
Menu